Company / R&D per Share
Minerva Neurosciences, Inc. R&D per Share History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.70
FY2024
5-year range
$0.52 / $6.00
FY2020-FY2024
Trend
-38.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 8 years, ranging from $0.52 in FY2021 to $6.00 in FY2022.
Based on SEC 10-K filings.
1.70 in FY2024 with a 5-year CAGR of +13.7%.
Declined from $6.00 to $1.70 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +48.9%
- 5-Year CAGR
- +13.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, r&d per share decreased 38.0% year-over-year.
- Peak r&d per share was recorded in FY2022.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.70 | -38.0% |
| FY2023 | $2.74 | -54.3% |
| FY2022 | $6.00 | +1063.0% |
| FY2021 | $0.52 | -65.3% |
| FY2020 | $1.49 | +66.0% |
| FY2019 | $0.90 | +14.8% |
| FY2018 | $0.78 | +47.6% |
| FY2017 | $0.53 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026